iPSC Disease Modeling | DefiniGEN

Enabling cures for liver disease through highly predictive in vitro modelling

DefiniGEN Laboratory

Cell-Based Bioassays

Our cell-based bioassays are developed following industry guidelines on bioanalytical method validation.

DefiniGEN vials in dry ice

Specialist CRO focused on delivering phenotypically relevant liver disease models

Physiologically relevant liver disease models that can be generated at scale for modeling, assay development and screening.

Advance your programme at speed with our in-house drug screening platform

By combining our expertise at generating iPSC-derived hepatocyte cellular models of disease with our wide panel of bespoke bioassays.

We work as partners with your team to design and implement in-house screening of small molecule and advanced genetic therapies, so you can advance your program at speed.